Showing results (51-60 of 94) with videos related to
Sort By:
Pageof 10
China CDC Weekly|July 11, 2026
Vaccination Coverage, Timeliness and Adverse Events Following Immunization in Children with Medical Conditions - Shandong Province, China, 2023Yudan Song, Xiang Zeng, Shaonan Liu, et al.China CDC Weekly|July 11, 2026
Factors Associated with Influenza Vaccination Among Children Aged 6 Months to 12 Years - Three Provinces, China, 2024-2025 Influenza SeasonJiayu He, Zundong Yin, Wenzhou Yu, et al.Human Vaccines & Immunotherapeutics|November 10, 2021
Caregivers' intentions to COVID-19 vaccination for their children in China: a cross-sectional surveyHuangyufei Feng, He Zhu, Haijun Zhang, et al.China CDC Weekly|July 5, 2024
The COVID-19 Vaccines Evaluation Program: Implementation, Management, and Experiences, 2021-2023Tingting Yan, Hui Zheng, Mingshuang Li, et al.China CDC Weekly|October 1, 2021
Progress Toward Measles Elimination - China, January 2013-June 2019Chao Ma, Lance Rodewald, Lixin Hao, et al.China CDC Weekly|December 30, 2024
Impact of Immunization Strategies on Rubella Incidence During Progress Toward Rubella Control and Elimination - China, 2004-2023Siyu Liu, Xia Xu, Qianqian Liu, et al.MMWR. Morbidity and Mortality Weekly Report|December 6, 2019
Progress Toward Measles Elimination - China, January 2013-June 2019Chao Ma, Lance Rodewald, Lixin Hao, et al.Vaccine|March 13, 2026
Post-marketing surveillance of adverse events following enterovirus type 71 inactivated vaccine in China, 2016-2023Keli Li, Yan Li, Lina Zhang, et al.Human Vaccines & Immunotherapeutics|May 13, 2021
Immunogenicity of trivalent seasonal influenza vaccine in patients with chronic obstructive pulmonary diseaseYan Li, Ying Ma, Zhijie An, et al.China CDC Weekly|October 1, 2021
Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Chronic Obstructive Pulmonary Disease - Hebei Province, China, September-December, 2019Yan Li, Ying Ma, Zhijie An, et al.Pageof 10